Cargando…

Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chjoong Howe Alvin, Tan, Eik Hock Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425229/
https://www.ncbi.nlm.nih.gov/pubmed/22942782
http://dx.doi.org/10.4103/1450-1147.98745
_version_ 1782241344049119232
author Tan, Chjoong Howe Alvin
Tan, Eik Hock Andrew
author_facet Tan, Chjoong Howe Alvin
Tan, Eik Hock Andrew
author_sort Tan, Chjoong Howe Alvin
collection PubMed
description Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a case where various molecular tracers (fluorodeoxyglucose, choline, and methoxyisobutylisonitrile) were used in the post-treatment assessment of a patient with histologically proven GBM.
format Online
Article
Text
id pubmed-3425229
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34252292012-09-01 Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline Tan, Chjoong Howe Alvin Tan, Eik Hock Andrew World J Nucl Med Case Report Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a case where various molecular tracers (fluorodeoxyglucose, choline, and methoxyisobutylisonitrile) were used in the post-treatment assessment of a patient with histologically proven GBM. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3425229/ /pubmed/22942782 http://dx.doi.org/10.4103/1450-1147.98745 Text en Copyright: © World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tan, Chjoong Howe Alvin
Tan, Eik Hock Andrew
Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
title Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
title_full Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
title_fullStr Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
title_full_unstemmed Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
title_short Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
title_sort post-treatment assessment of glioblastoma multiforme: imaging with fluorodeoxyglucose, sestamibi, and choline
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425229/
https://www.ncbi.nlm.nih.gov/pubmed/22942782
http://dx.doi.org/10.4103/1450-1147.98745
work_keys_str_mv AT tanchjoonghowealvin posttreatmentassessmentofglioblastomamultiformeimagingwithfluorodeoxyglucosesestamibiandcholine
AT taneikhockandrew posttreatmentassessmentofglioblastomamultiformeimagingwithfluorodeoxyglucosesestamibiandcholine